Skip to main content

Table 1 Assessing CEA evidence using shadow prices in Australia: NHMRC [9]

From: International lessons in new methods for grading and integrating cost effectiveness evidence into clinical practice guidelines

Ranking of evidence on costs

Ranking of evidence on effects

High

Low

Strong

Recommend if:

Recommend if:

<$70,000 per life-year

<$30,000 per life-year

Do not recommend if

Do not recommend if

>$100,000 per life-year

>$70,000 per life-year

Weak

Recommend if:

Recommend if:

<$30,000 per life-year

<$30,000 per life-year

Do not recommend if

Do not recommend if

>$70,000 per life-year

>$30,000 per life-year